CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-24 | Versant Venture Capital V, L.P. 10% owner | Sale | −1,528 | $51.00 | $78K | 115,645 |
| 2018-04-23 | Versant Venture Capital IV, L.P. 10% owner | Sale | −89,628 | $50.66 | $4.5M | 1,539,576 |
| 2018-04-23 | Versant Venture Capital IV, L.P. 10% owner | Sale | −2,630 | $51.00 | $134K | 45,171 |
| 2018-04-23 | Versant Venture Capital IV, L.P. 10% owner | Sale | −2,915 | $51.00 | $149K | 50,072 |
| 2018-04-23 | Versant Venture Capital IV, L.P. 10% owner | Sale | −6,821 | $50.66 | $346K | 117,173 |
| 2018-04-23 | Woiwode Thomas Director | Sale | −89,628 | $50.66 | $4.5M | 1,539,576 |
| 2018-04-23 | Woiwode Thomas Director | Sale | −2,630 | $51.00 | $134K | 45,171 |
| 2018-04-23 | Woiwode Thomas Director | Sale | −2,915 | $51.00 | $149K | 50,072 |
| 2018-04-23 | Woiwode Thomas Director | Sale | −6,821 | $50.66 | $346K | 117,173 |
| 2018-04-23 | Bolzon Bradley J PhD Director | Sale | −89,628 | $50.66 | $4.5M | 1,539,576 |
| 2018-04-23 | Bolzon Bradley J PhD Director | Sale | −2,630 | $51.00 | $134K | 45,171 |
| 2018-04-23 | Bolzon Bradley J PhD Director | Sale | −2,915 | $51.00 | $149K | 50,072 |
| 2018-04-23 | Bolzon Bradley J PhD Director | Sale | −6,821 | $50.66 | $346K | 117,173 |
| 2018-04-20 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −497,053 | 2,238,979 | ||
| 2018-04-20 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −2,947 | 13,277 | ||
| 2018-04-20 | Versant Venture Capital IV, L.P. 10% owner | Other acquisition | +92,918 | 92,918 | ||
| 2018-04-20 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −92,918 | 0 | ||
| 2018-04-20 | Woiwode Thomas Director | Other disposition | −497,053 | 2,238,979 | ||
| 2018-04-20 | Woiwode Thomas Director | Other disposition | −2,947 | 13,277 | ||
| 2018-04-20 | Woiwode Thomas Director | Other acquisition | +92,918 | 92,918 |
Page 54 of 62 · 1,221 trades